Mohammad
Danielle Freedman is putting together the RCPath SAC response for our
discipline and, from the discussion at the recent Clin Biochem SAC meeting,
is likely to address many of the points you raise.
I think I am correct in saying that the documents from all the SAC
specialities will be submitted together.
Eric
Dr. Eric S. Kilpatrick
Consultant in Chemical Pathology
Department of Clinical Biochemistry
Hull Royal Infirmary
Anlaby Road
Hull HU3 2JZ
Tel 01482-607708
Fax 01482-607752
>From: Mohammad Al-Jubouri <[log in to unmask]>
>Reply-To: Mohammad Al-Jubouri <[log in to unmask]>
>To: [log in to unmask]
>Subject: Re: Lord Carter's review[Scanned]
>Date: Mon, 23 Jan 2006 14:20:54 +0000
>
>Thanks Mike
>
>The RCPath response was a good collective response, however the SAC
>histopathology response is self centred and didn't acknowledge any link
>between histopathology and other lab disciplines. Whilst, I acknowlege that
>this was a speciality specific response, the message it sends out that
>pathology can be broken down is the very evidence that this review panel
>seeks in their quest for the "few megalabs and widespread POCT" model. I
>would hope that our speciality response be more accomodating of other lab
>disciplines and should include:
>
>1. Pathology is integral to patient's care, and any major service
>reconfiguration should not lose sight of this important clinical function.
>
>2. Importance of multidisciplinary nature of pathology reflecting its
>complex nature and its requirement of highly skilled staff, appropriate
>premises and state of the art equipment.
>
>3. Local pathology modernisation initiatives should be acknowleged and
>build upon them.
>
>4. CPA and quality issues are vital.
>
>5. Educational role of the lab for clinicians as well as its staff,
>ensuring provision of qualified staff who had good exposure to pathology.
>
>6. Labs heavy involvement in audit and research, the essential component of
>clinical governance.
>
>7. Patient's centered targets are already supported by pathology labs
>through rapid turnaround times.
>
>8. Access and choice for patients, means better phlebotomy and transport of
>samples arrangements.
>
>9. Widespread POCT is likely to result in fragmentation of service with
>rising cost and risk but without any evidence of improved patient's
>outcome. However rational use of POCT with direct support from the local
>lab to ensure that quality and patien's safety are not compromised.
>
>10. Private sector involvement is welcome as long as they are subjected to
>the same rigorous criteria as NHS labs regarding quality and other service
>specifications.
>
>Best wishes
>
>Mohammad
>
> >>> "Hallworth Mike (RLZ)" <[log in to unmask]> 23/01/2006 12:31:30
> >>>
>The ACB are preparing a detailed response.
>
>Mike
>
>
>
>-----Original Message-----
>From: Mohammad Al-Jubouri [mailto:[log in to unmask]]
>Sent: 23 January 2006 12:21
>To: [log in to unmask]
>Subject: Lord Carter's review
>
>
>Dear UK list members
>The deadline for submission of responses to the above review is by the end
>of this month, do any of you know if a response is being submitted on
>behalf
>of our speciality by the ACB, SAC clinical biochemistry or any other body.
>The SAC for histopathology has submitted a comprehensive response (5 pages
>document) arguing against the usefulness of POCT in cellular pathology, a
>unique discipline!!!
>
>regards
>
>Mohammad
>
>
>
>Dr. M A Al-Jubouri
>Consultant Chemical Pathologist
>
>
>
> _____
>
>Win a BlackBerry device from O2 with Yahoo!.
><http://us.rd.yahoo.com/mail/uk/taglines/default/mobile_o2/*http://www.yahoo
>.co.uk/blackberry> Enter now. ------ACB discussion List Information--------
>This is an open discussion list for the academic and clinical community
>working in clinical biochemistry. Please note, archived messages are public
>and can be viewed via the internet. Views expressed are those of the
>individual and they are responsible for all message content.
>
>ACB Web Site http://www.acb.org.uk List Archives
>http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions
>(How to leave etc.) http://www.jiscmail.ac.uk/
>
>This electronic message may contain information from Shrewsbury and Telford
>Hospital NHS Trust which may be privileged or confidential. The information
>is intended to be for the use of the individual(s) or entity named above.
>If
>you are not the intended recipient be aware that any disclosure, copying,
>distribution or use of the contents of this information is prohibited. If
>you have received this electronic message in error, please notify us by
>telephone or email (to the numbers or address above) immediately.
>
>------ACB discussion List Information--------
>This is an open discussion list for the academic and clinical
>community working in clinical biochemistry.
>Please note, archived messages are public and can be viewed
>via the internet. Views expressed are those of the individual and
>they are responsible for all message content.
>
>ACB Web Site
>http://www.acb.org.uk
>List Archives
>http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
>List Instructions (How to leave etc.)
>http://www.jiscmail.ac.uk/
>------------------------------------------------------------------------------------------------------------------
>Virus Scanned and Verified by St Helens & Knowsley Health Informatics
>------------------------------------------------------------------------------------------------------------------
>DISCLAIMER: This e-mail may contain confidential and/or proprietary
>information some or all of which may be legally privileged.
>It is for the intended recipient only. If any addressing or transmission
>error has misdirected this e-mail, please notify the author by replying to
>this e-mail and destroy any copies.
>If you are not the intended recipient you must not use, disclose,
>distribute, copy, print, or rely on this e-mail.
>The information contained in this email may be subject to public disclosure
>under the Freedom of Information Act 2000.
>Unless the information is legally exempt from disclosure, the
>confidentiality of this email AND YOUR REPLY cannot be guaranteed.
>
>------ACB discussion List Information--------
>This is an open discussion list for the academic and clinical
>community working in clinical biochemistry.
>Please note, archived messages are public and can be viewed
>via the internet. Views expressed are those of the individual and
>they are responsible for all message content.
>
>ACB Web Site
>http://www.acb.org.uk
>List Archives
>http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
>List Instructions (How to leave etc.)
>http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|
